LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $33,908,000 | +7.9% | 4,551,343 | +0.7% | 4.33% | -31.7% |
| Q4 2016 | $31,418,000 | -10.3% | 4,520,643 | +6.2% | 6.35% | +3.2% |
| Q3 2016 | $35,038,000 | -0.3% | 4,257,347 | -1.9% | 6.15% | -21.3% |
| Q2 2016 | $35,142,000 | +121.4% | 4,338,557 | +38.8% | 7.81% | +41.0% |
| Q1 2016 | $15,876,000 | -35.5% | 3,125,198 | -2.0% | 5.54% | -34.7% |
| Q4 2015 | $24,608,000 | +34.3% | 3,187,607 | +0.2% | 8.48% | +78.0% |
| Q3 2015 | $18,322,000 | -31.6% | 3,180,913 | +8.8% | 4.76% | -35.5% |
| Q2 2015 | $26,805,000 | +3.0% | 2,923,065 | +36.0% | 7.38% | -26.1% |
| Q1 2015 | $26,035,000 | – | 2,149,907 | – | 9.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |